Article
Pharmacology & Pharmacy
Qiong-Ying Hu, Xiao-Kun Zhang, Jia-Nan Wang, Hao-Xuan Chen, Lian-Ping He, Jin-Shan Tang, Xin-Sheng Yao, Jie Liu
Summary: Studies have shown that malayoside has anti-NSCLC activity both in vitro and in vivo, mainly through activation of the MAPK-Nur77 signaling pathway, indicating that malayoside is a promising chemotherapeutic candidate for NSCLC.
BIOCHEMICAL PHARMACOLOGY
(2021)
Article
Environmental Sciences
Han Song, Junjun Qiu, Keqin Hua
Summary: USP14 is overexpressed in cervical cancer and is associated with clinical stage and prognosis of patients. It promotes the proliferation, migration, and invasion of cervical cancer cells by upregulating the expression of beta-catenin.
ENVIRONMENTAL TOXICOLOGY
(2023)
Review
Biotechnology & Applied Microbiology
Arundhathi Dev, Meenakshi Vachher, Chandra Prakash Prasad
Summary: beta-catenin is a crucial protein involved in various cellular processes, including cellular homeostasis, embryonic development, and cancer. It functions as a signaling molecule and also plays a role in cell adhesion. Aberrant expression of beta-catenin promotes the transcription of oncogenes and contributes to tumorigenesis. Understanding the regulation of beta-catenin is important for understanding the mechanisms of cancer progression.
Article
Biochemistry & Molecular Biology
Shoji Miyako, Takeru Matsuda, Yu-ichiro Koma, Takahiro Koide, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Taro Oshikiri, Yoshihiro Kakeji
Summary: This study aimed to investigate the association of Wnt/beta-catenin signal activation with a pathological response to neoadjuvant chemoradiotherapy (NACRT) in patients with locally advanced rectal cancer. The results showed that activation of the Wnt/beta-catenin signal pathway represented by nuclear beta-catenin accumulation was significantly associated with a poor response to NACRT. Therefore, analysis of nuclear beta-catenin accumulation before starting treatment might help predict the therapeutic response to NACRT.
Article
Oncology
Chun Tang, Xuehui Wang, Changle Ji, Wenfang Zheng, Yunhe Yu, Xiaochong Deng, Xiqian Zhou, Lin Fang
Summary: The study demonstrated that miR-640 suppresses the tumorigenesis of breast cancer cells by regulating the Wnt/β-catenin signaling pathway, making it a potential novel target for targeted therapy in breast cancer.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Xinyu Li, Wen Chen, Chunkang Yang, Yisen Huang, Jing Jia, Rongyu Xu, Shen Guan, Ruijun Ma, Haitao Yang, Lifeng Xie
Summary: IGHG1 acts as an oncogene in gastric cancer by promoting cellular proliferation, migration, and chemo-resistance, and it activates the AKT/GSK-3/beta-Catenin axis to regulate these behaviors in gastric cancer cells.
CANCER CELL INTERNATIONAL
(2021)
Article
Medicine, Research & Experimental
Heyu Song, Ricky A. Sontz, Matthew J. Vance, Julia M. Morris, Sulaiman Sheriff, Songli Zhu, Suzann Duan, Jiping Zeng, Erika Koeppe, Ritu Pandey, Curtis A. Thorne, Elena M. Stoffel, Juanita L. Merchant
Summary: The incidence of early-onset colorectal cancer (EO-CRC) is rising, with lifestyle factors and genetic background playing a potential role. The study found a missense mutation, HNF1AA98V, in the Hepatic Nuclear Factor 1α (HNF1A) gene, which reduces DNA binding ability. In mice, introducing the HNF1AA98V variant and feeding a high-fat or high-sugar diet led to an increased formation of colonic polyps. The study also revealed alterations in gene expression and signaling pathways related to metabolism, immunity, and lipid biogenesis.
Article
Biochemistry & Molecular Biology
Maria Abancens, Brian J. Harvey, Jean McBryan
Summary: Women have lower incidence and mortality rates for colorectal cancer compared to men. Estrogen may protect against colorectal cancer progression through GPER-mediated modulation of the Wnt/beta-catenin pathway.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Pharmacology & Pharmacy
Tianye Li, Zihan Tang, Chunting Li, Xiaoya Liu, Linglin Cheng, Zhijing Yang, Xiaojin Zhu, Weiwei Liu, Yongye Huang
Summary: This study found that co-treatment with cisplatin and magnesium chloride (MgCl2) reduced the survival rate and colony formation of bladder cancer cells. The combination therapy also increased the proportion of apoptotic cells. Magnesium was shown to moderately regulate the Wnt/β-catenin signaling pathway, enhancing the efficacy of cisplatin-based chemotherapy.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Oncology
Minhong Shen, Shanshan Xie, Michelle Rowicki, Sven Michel, Yong Wei, Xiang Hang, Liling Wan, Xin Lu, Min Yuan, John F. Jin, Frank Jaschinski, Tianhua Zhou, Richard Klar, Yibin Kang
Summary: The study found that MTDH promotes the progression of colorectal and lung cancers by facilitating Wnt activation and inducing T-cell exhaustion. Treatment with MTDH antisense oligonucleotides effectively suppresses MTDH expression and significantly attenuates the progression and metastasis of these cancers.
Article
Biochemistry & Molecular Biology
Tian-Huei Chu, Chou-Yuan Ko, Po-Han Tai, Yi-Chen Chang, Chao-Cheng Huang, Tung-Yang Wu, Hoi-Hung Chan, Ping-Hsuan Wu, Chien-Hui Weng, Yu-Wei Lin, Mei-Lang Kung, Cheng-Chieh Fang, Jian-Ching Wu, Zhi-Hong Wen, Yung-Kuo Lee, Tsung-Hui Hu, Ming-Hong Tai
Summary: In this study, it was found that LECT2 expression in HCC is associated with tumor development and patient survival. Functional assays revealed that LECT2 can suppress oncogenic behaviors in hepatoma cells and inhibit CSC functions. Increasing LECT2 expression through therapy could effectively treat HCC by suppressing the HGF/c-MET axis to reduce CSC expansion.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2022)
Article
Oncology
Yang Zhou, Jiang Xu, Haichang Luo, Xiangjing Meng, Ming Chen, Di Zhu
Summary: Abnormal activation of the Wnt/beta-catenin signaling pathway is closely related to tumorigenesis and immune surveillance, leading to increased resistance to immunotherapy.
Article
Biochemistry & Molecular Biology
Chuan-Jian Shi, Shi-Ying Li, Chun-Hui Shen, Fei-Fei Pan, Li-Qiang Deng, Wei-Ming Fu, Ji-Yong Wang, Jin-Fang Zhang
Summary: In this study, it was found that Icariside II suppressed the proliferation of colorectal cancer (CRC) by inducing cell cycle arrest and apoptosis. It also inhibited tumor growth in vivo by suppressing the expression of beta-catenin and inactivating the Wnt/beta-catenin signaling pathway. Furthermore, Icariside II was shown to epigenetically target DNA methyltransferases (DNMTs) and decrease global DNA methylation levels, resulting in the suppression of circ beta-catenin biogenesis.
BIOORGANIC CHEMISTRY
(2022)
Review
Oncology
Matthias Christgen, Gabor Cserni, Giuseppe Floris, Caterina Marchio, Lounes Djerroudi, Hans Kreipe, Patrick W. B. Derksen, Anne Vincent-Salomon
Summary: This review summarizes the development of microscopic assessment of invasive lobular breast cancer (ILC) from 1941 until today, discussing various concepts and implications, providing an overview of ILC variants, and highlighting recent advances contributing to a better understanding of the special histologic spectrum of ILC.
Article
Biochemistry & Molecular Biology
Junrong Liang, Lina Sun, Yujun Li, Wanning Liu, Danxiu Li, Ping Chen, Xin Wang, Juan Hui, Jinchi Zhou, Hao Liu, Tianyu Cao, Maogui Pang, Meng Guo, Xin Wang, Xiaodi Zhao, Yuanyuan Lu
Summary: This study investigated the expression and function of DKK4 in colorectal cancer (CRC). The results showed that DKK4 was upregulated in CRC cell lines and tissues, and it inhibited cell metastasis by repressing the Wnt signaling pathway. Through experiments and analysis, the researchers also revealed the regulatory mechanism of DKK4 and its potential therapeutic application.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2022)
Article
Oncology
Cheng Xing, Xing-Xing Lu, Peng-Da Guo, Tong Shen, Shen Zhang, Xiao-Shun He, Wen-Juan Gan, Xiu-Ming Li, Jing-Ru Wang, Yuan-Yuan Zhao, Hua Wu, Jian-Ming Li
Article
Oncology
Hua Wu, Xiu-Ming Li, Jing-Ru Wang, Wen-Juan Gan, Fu-Quan Jiang, Yao Liu, Xin-Dao Zhang, Xiao-Shun He, Yuan-Yuan Zhao, Xing-Xing Lu, Yan-Bing Guo, Xiao-Kun Zhang, Jian-Ming Li
JOURNAL OF PATHOLOGY
(2016)
Article
Gastroenterology & Hepatology
Hua Wu, Su Yao, Shen Zhang, Jing-Ru Wang, Peng-Da Guo, Xiu-Ming Li, Wen-Juan Gan, Lin Mei, Tian-Ming Gao, Jian-Ming Li
JOURNAL OF HEPATOLOGY
(2017)
Article
Oncology
Xiu-Ming Li, Tian-Yu Yang, Xiao-Shun He, Jing-Ru Wang, Wen-Juan Gan, Shen Zhang, Jian-Ming Li, Hua Wu
Article
Multidisciplinary Sciences
Xiu-Ming Li, Jing-Ru Wang, Tong Shen, Shang-Shang Gao, Xiao-Shun He, Jiang-Nan Li, Tian-Yu Yang, Shen Zhang, Wen-Juan Gan, Jian-Ming Li, Hua Wu
Article
Cell Biology
Hua Wu, Xing-Xing Lu, Jing-Ru Wang, Tian-Yu Yang, Xiu-Ming Li, Xiao-Shun He, Yi Li, Wen-Long Ye, Yong Wu, Wen-Juan Gan, Peng-Da Guo, Jian-Ming Li
Article
Multidisciplinary Sciences
Xiaohong Ye, Hua Wu, Luoyan Sheng, Yi-xin Liu, Fang Ye, Mo Wang, Hu Zhou, Ying Su, Xiao-kun Zhang
NATURE COMMUNICATIONS
(2019)
Article
Oncology
Yanmin Xu, Huailong Xu, Mingyuan Li, Hua Wu, Yanhe Guo, Jun Chen, Juanjuan Shan, Xuejiao Chen, Junjie Shen, Qinghua Ma, Jingxia Liu, Meiling Wang, Wenxu Zhao, Juan Hong, Yanan Qi, Chao Yao, Qianzhen Zhang, Zhi Yang, Cheng Qian, Jianming Li
Article
Gastroenterology & Hepatology
Hua Wu, Tian-Yu Yang, Yi Li, Wen-Long Ye, Feng Liu, Xiao-Shun He, Jing-Ru Wang, Wen-Juan Gan, Xiu-Ming Li, Shen Zhang, Yuan-Yuan Zhao, Jian-Ming Li
Article
Immunology
Yun Yang, Xiu-Ming Li, Jing-Ru Wang, Yan Li, Wen-Long Ye, Yi Wang, Yu-Xuan Liu, Zhi-Yong Deng, Wen-Juan Gan, Hua Wu
Summary: TRIP6, a member of the zyxin family, serves as an adaptor protein to regulate various biological processes. Through interactions with TRAF6, it is shown to play a positive regulatory role in DSS-induced colitis, activating inflammatory TRAF6 signaling.
JOURNAL OF INFLAMMATION-LONDON
(2022)
Article
Biochemistry & Molecular Biology
Xiao-Shun He, Wen-Long Ye, Yu-Juan Zhang, Xiao-Qin Yang, Feng Liu, Jing-Ru Wang, Xiao-Lu Ding, Yun Yang, Ruo-Nan Zhang, Yuan-Yuan Zhao, Hai-Xia Bi, Ling-Chuan Guo, Wen-Juan Gan, Hua Wu
Summary: In this study, we found that BEST4 promotes cell proliferation and metastasis in colorectal cancer. It activates the Akt signaling pathway by binding to the regulatory subunit p85 alpha of PI3K, leading to the expression of critical regulators such as MYC and CCND1. Additionally, high expression of BEST4 is associated with poor prognosis in patients.
Article
Biochemistry & Molecular Biology
Xiao-Shun He, Sheng-Yi Zou, Jia-Lu Yao, Wangjianfei Yu, Zhi-Yong Deng, Jing-Ru Wang, Wen-Juan Gan, Shan Wan, Xiao-Qin Yang, Hua Wu
Summary: The study identified complement component 3 (C3) gene as the hub gene associated with both FOLFOX resistance and CRC recurrence. High C3 expression was found to be detrimental for patient survival and oxaliplatin sensitivity in CRC. In addition, C3 expression correlated with tumor microenvironment changes and hyperactivation of pathways contributing to invasion, metastasis, lymph node spread, and oxaliplatin resistance in CRC samples.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2021)
Editorial Material
Integrative & Complementary Medicine
Chunpeng (Craig) Wan, Muhammad Farrukh Nisar, Hua Wu
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Yu-Xuan Liu, Shan Wan, Xiao-Qin Yang, Yi Wang, Wen-Juan Gan, Wen-Long Ye, Xiao-Shun He, Jun-Jie Chen, Yun Yang, Xue-Mei Yang, Xin Guo, Xiao-Jiao Gao, Yi-Tan Lu, Zhi-Yong Deng, Guang Hu, Hua Wu
Summary: This study identified TRIM21 as a protein that inhibits invasion and metastasis in colorectal cancer through its interaction with MST2. It was also found that the antidepressant vilazodone can exert anti-metastatic effects by binding to TRIM21. These findings reveal a previously unrecognized interplay between TRIM21 and the Hippo-YAP signaling pathway, and suggest that vilazodone could be repurposed as an anti-tumor drug to inhibit colorectal cancer metastasis by targeting TRIM21.
CELL CHEMICAL BIOLOGY
(2023)
Article
Oncology
Xiao-Shun He, Ling-Chuan Guo, Ming-Zhan Du, Shan Huang, Ren-Peng Huang, Sheng-Hua Zhan, Dong-Mei Gu, Wei-Shuo Liu, Xi-Ming Wang, Hua Wu, Wen-Juan Gan